Sonoma Pharmaceuticals (SNOA) Interest Coverage Ratio Growth (3y) (2013 - 2026)
Sonoma Pharmaceuticals (SNOA) Interest Coverage Ratio Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -3.69% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 75.30% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -72.71% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | -2.64% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 37.62% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.12 Mn | -222,819.83 | 2.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 74.00% |
| Mar 31, 2026 | 33.56% |
| Dec 31, 2025 | -154.33% |
| Sep 30, 2025 | 21.77% |
| Jun 30, 2025 | -50.59% |
| Mar 31, 2025 | 4.99% |
| Sep 30, 2024 | -57.55% |
| Jun 30, 2024 | -250.58% |
| Dec 31, 2023 | -274.20% |
| Sep 30, 2023 | -147.01% |
| Jun 30, 2023 | -160.03% |
| Mar 31, 2023 | 40.24% |
| Dec 31, 2022 | 85.42% |
| Sep 30, 2022 | -4.34% |
| Jun 30, 2022 | 41.44% |
| Mar 31, 2022 | 12.93% |
| Dec 31, 2021 | 41.15% |
| Sep 30, 2021 | 85.20% |
| Jun 30, 2021 | 84.35% |
| Dec 31, 2020 | 73.34% |